Background: The pharmacy profession has significantly changed over the years. Pharmacy students' perceptions of their coursework and future career aspirations may vary in relation to gender.
Objectives: The present study explored the motivations of pharmacy students to enter pharmacy school, their satisfaction with the academic program, future plans after graduation, and perceptions about the pharmacy profession in relation to gender.
Methods: Data were collected using a cross-sectional descriptive validated questionnaire built by the research team. The study was conducted at twelve public and private universities offering pharmacy programs.
Results: In total, 918 pharmacy students have completed the online questionnaire, with a 98% response rate. Most participants reported that family encouragement was a motive to enter pharmacy school. The results of the Chi-Squared Test indicated a significant difference between female and male participants with respect to the following motives: High school grades (p = 0.009), being good at science (p = 0.013), working with patients(p = 0.024), professional status (p = 0.014), working in a family business (p = 0.001) and job opportunities (p = 0.001). The majority of male participants and female participants perceived pharmacy jobs as prestigious jobs. In addition, male and female students believed that it was a profession with well-paid jobs.
Conclusion: Females were significantly more motivated by their high school degrees, goodness at science, working with patients, and professional status to enter pharmacy school. Pharmacy students are satisfied enough with the academic program. Male and female pharmacists have different career aspirations in the pharmaceutical sectors. It is recommended that students be educated about career planning to help them accomplish their goals. Future research could benefit from longitudinal studies to explore changes in pharmacy students' motivations, satisfaction, and career aspirations over time.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875339 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0317896 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Engineering Perovskite Hydroxide as a Cold-Adapted Oxidase Mimic for Construction of the Robust Low-Temperature Adaptive Biosensors.
ACS Sens
March 2025
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.
Traditional biological detection methods rely on signal amplification strategies such as enzymatic catalysis or nucleic acid amplification. However, their efficiency decreases in low-temperature environments, compromising their detection sensitivity. To break the loss of enzyme catalytic activity at low temperatures, research on cold-adaptive nanozymes has attracted much attention.
View Article and Find Full Text PDFWorldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.
Oncotarget
March 2025
Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France.
The human genome project ushered in a genomic medicine era that was largely unimaginable three decades ago. Discoveries of druggable cancer drivers enabled biomarker-driven gene- and immune-targeted therapy and transformed cancer treatment. Minimizing treatment not expected to benefit, and toxicity-including financial and time-are important goals of modern oncology.
View Article and Find Full Text PDFAI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity.
J Med Chem
March 2025
State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine; Shanghai Frontiers Science Center of TCM Chemical Biology; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
The anticancer agent irinotecan often induces severe delayed-onset diarrhea, inhibiting human carboxylesterase 2A (hCES2A) can significantly alleviate irinotecan-triggered gut toxicity (ITGT). This work presents an efficient workflow for design and developing novel efficacious hCES2A inhibitors. A well-training machine learning model identified as a lead compound, while compound was developed as a novel time-dependent hCES2A inhibitor (IC = 0.
View Article and Find Full Text PDFAstracondensatol D: A 6/6/5/6 Cycloartane Triterpenoid from .
Org Lett
March 2025
National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, Mississippi 38677, United States.
Astracondensatol D (), a pentacyclic triterpenoid featuring an uncommon 6/6/5/6-fused ring system, along with its precursor astracondensatol E (), and two simplified 20(27)-octanorcycloastragenol derivatives ( and ) were isolated from for the first time. Classical NMR spectroscopic data, integrated with NMR and DP4+ calculations, unambiguously determined their absolute stereostructures. X-ray crystallography provided independent confirmation of the structure of compound .
View Article and Find Full Text PDFAggregatin is a mitochondrial regulator of MAVS activation to drive innate immunity.
J Immunol
February 2025
Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, United States.
Mitochondrial antiviral-signaling protein (MAVS) is a key adapter protein required for inducing type I interferons (IFN-Is) and other antiviral effector molecules. The formation of MAVS aggregates on mitochondria is essential for its activation; however, the regulatory mitochondrial factor that mediates the aggregation process is unknown. Our recent work has identified the protein Aggregatin as a critical seeding factor for β-amyloid peptide aggregation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!